{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:21:16Z","timestamp":1789402876425,"version":"build-2803163510"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dose-dependent effects of inhaled corticosteroids have been described. Although it has been advised to start treatment with inhaled corticosteroids with a high dose tapering off subsequently (stepdown approach), no clinical studies have assessed this strategy. We compared two different dosage schedules of inhaled fluticasone propionate (FP) in chronic persistent childhood asthma with respect to efficacy (airways hyperresponsiveness [PD20], lung function, exhaled nitric oxide [eNO]) and safety (height). During this double-blind study, children with asthma (aged 6\u201310 yr) were randomized to receive either FP 200 \u03bc g\/d (constant dose approach) or to start with 1000 \u03bc g\/d with two monthly reductions to 500, 200, and 100 \u03bc g\/d (stepdown approach). PD20 improved in both approaches during treatment with FP, with a significantly better PD20 after 2 mo of 1000 \u03bc g\/d followed by 500 \u03bc g\/d in the stepdown approach versus 200 \u03bc g\/d in the constant dose approach. No significant differences in PD20 or other efficacy parameters were found after 1 yr. Changes in standing height were similar in both treatment approaches. This study showed no superior clinical effect of a stepdown approach compared with a constant dose strategy of FP for 1 yr in children with chronic persistent asthma.<\/jats:p>","DOI":"10.1164\/ajrccm.164.11.2103075","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:44:46Z","timestamp":1365086686000},"page":"2073-2077","source":"Crossref","is-referenced-by-count":43,"title":["One-Year Treatment with Different Dosing Schedules of Fluticasone Propionate in Childhood Asthma"],"prefix":"10.1093","volume":"164","author":[{"given":"MARTIN J.","family":"VISSER","sequence":"first","affiliation":[{"name":"Department of Pulmonology and Pediatric Pulmonology, University Hospital, Groningen; Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam; Department of Pediatrics, Medical Center, Leeuwarden; and Department of Pediatrics, Division of Pediatric Pulmonology, Isala Klinieken, Zwolle, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DIRKJE S.","family":"POSTMA","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Pediatric Pulmonology, University Hospital, Groningen; Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam; Department of Pediatrics, Medical Center, Leeuwarden; and Department of Pediatrics, Division of Pediatric Pulmonology, Isala Klinieken, Zwolle, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIDIA R.","family":"ARENDS","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Pediatric Pulmonology, University Hospital, Groningen; Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam; Department of Pediatrics, Medical Center, Leeuwarden; and Department of Pediatrics, Division of Pediatric Pulmonology, Isala Klinieken, Zwolle, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TJALLING W.","family":"DE VRIES","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Pediatric Pulmonology, University Hospital, Groningen; Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam; Department of Pediatrics, Medical Center, Leeuwarden; and Department of Pediatrics, Division of Pediatric Pulmonology, Isala Klinieken, Zwolle, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ERIC J.","family":"DUIVERMAN","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Pediatric Pulmonology, University Hospital, Groningen; Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam; Department of Pediatrics, Medical Center, Leeuwarden; and Department of Pediatrics, Division of Pediatric Pulmonology, Isala Klinieken, Zwolle, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAUL L. P.","family":"BRAND","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Pediatric Pulmonology, University Hospital, Groningen; Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam; Department of Pediatrics, Medical Center, Leeuwarden; and Department of Pediatrics, Division of Pediatric Pulmonology, Isala Klinieken, Zwolle, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12,1]]},"reference":[{"key":"2026032708131680100_B1"},{"key":"2026032708131680100_B2"},{"key":"2026032708131680100_B3"},{"key":"2026032708131680100_B4"},{"key":"2026032708131680100_B5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1164\/ajrccm.160.1.9811024","article-title":"The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study.","volume":"160","author":"Bisgaard","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708131680100_B6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/ajrccm.158.1.9706048","article-title":"Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group.","volume":"158","author":"Verberne","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708131680100_B7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1099-0496(200006)29:6<415::AID-PPUL1>3.0.CO;2-7","article-title":"Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma.","volume":"29","author":"Hofstra","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"2026032708131680100_B8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1542\/peds.103.2.414","article-title":"A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.","volume":"103","author":"Baker","year":"1999","journal-title":"Pediatrics"},{"key":"2026032708131680100_B9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-6749(95)70149-4","article-title":"Budesonide treatment of moderate and severe asthma in children: a dose-response study.","volume":"95","author":"Pedersen","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708131680100_B10","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-3476(98)70394-4","article-title":"Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.","volume":"132","author":"Shapiro","year":"1998","journal-title":"J Pediatr"},{"key":"2026032708131680100_B11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0954-6111(94)90044-2","article-title":"Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.","volume":"88","author":"Agertoft","year":"1994","journal-title":"Respir Med"},{"key":"2026032708131680100_B12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1651-2227.1996.tb13989.x","article-title":"Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers.","volume":"85","author":"Wennergren","year":"1996","journal-title":"Acta Paediatr"},{"key":"2026032708131680100_B13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0091-6749(98)70405-1","article-title":"Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes.","volume":"101","author":"Volovitz","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708131680100_B14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/(SICI)1099-0496(199709)24:3<178::AID-PPUL3>3.0.CO;2-J","article-title":"Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.","volume":"24","author":"Price","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"2026032708131680100_B15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0022-3476(98)70023-X","article-title":"Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.","volume":"132","author":"Allen","year":"1998","journal-title":"J Pediatr"},{"key":"2026032708131680100_B16","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1542\/peds.106.1.e8","article-title":"The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis.","volume":"106","author":"Sharek","year":"2000","journal-title":"Pediatrics"},{"key":"2026032708131680100_B17","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1056\/NEJM200010123431502","article-title":"Effect of long-term treatment with inhaled budesonide on adult height in children with asthma.","volume":"343","author":"Agertoft","year":"2000","journal-title":"N Engl J Med"},{"key":"2026032708131680100_B18"},{"key":"2026032708131680100_B19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1183\/09031936.01.17508870","article-title":"The feasibility of airways hyperresponsiveness as an inclusion criterion for studies on childhood asthma.","volume":"17","author":"Kamps","year":"2001","journal-title":"Eur Respir J"},{"key":"2026032708131680100_B20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"key":"2026032708131680100_B21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thx.45.3.199","article-title":"thoe Schwartzenberg GW, Hop WC, van Essen-Zandvliet EE, Kerrebijn KF. Does the outcome of the tidal breathing and dosimeter methods of assessing bronchial responsiveness in children with asthma depend on age?","volume":"45","author":"Birnie","year":"1990","journal-title":"Thorax"},{"key":"2026032708131680100_B22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/(SICI)1099-0496(200006)29:6<434::AID-PPUL4>3.0.CO;2-U","article-title":"Exhaled nitric oxide in children measured by tidal breathing method: differences between asthmatics and nonasthmatic controls.","volume":"29","author":"Visser","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"2026032708131680100_B23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0300-595X(86)80005-6","article-title":"Normal growth and techniques of growth assessment.","volume":"15","author":"Tanner","year":"1986","journal-title":"Clin Endocrinol Metab"},{"key":"2026032708131680100_B24","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1164\/ajrccm.149.6.8004295","article-title":"Measurement of functional severity of asthma in children.","volume":"149","author":"Rosier","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708131680100_B25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/ajrccm\/146.3.547","article-title":"Effects of 22 months of treatment with inhaled corticosteroids and\/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.","volume":"46","author":"van Essen-Zandvliet","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2026032708131680100_B26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1164\/ajrccm.156.3.9611067","article-title":"Kerrebijn KF. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group.","volume":"156","author":"Verberne","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708131680100_B27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199211123272003","article-title":"A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.","volume":"327","author":"Kerstjens","year":"1992","journal-title":"N Engl J Med"},{"key":"2026032708131680100_B28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1399-3003.2000.16b08.x","article-title":"Optimal asthma control, starting with high doses of inhaled budesonide.","volume":"16","author":"Reddel","year":"2000","journal-title":"Eur Respir J"},{"key":"2026032708131680100_B29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1183\/09031936.00.15101100","article-title":"Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.","volume":"15","author":"Gershman","year":"2000","journal-title":"Eur Respir J"},{"key":"2026032708131680100_B30","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1164\/ajrccm\/148.5.1252","article-title":"Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group.","volume":"148","author":"Waalkens","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2026032708131680100_B31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0091-6749(87)80163-X","article-title":"Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma.","volume":"79","author":"Kerrebijn","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708131680100_B32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3476(97)70204-X","article-title":"Expired nitric oxide as a marker for childhood asthma.","volume":"130","author":"Nelson","year":"1997","journal-title":"J Pediatr"},{"key":"2026032708131680100_B33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF01957156","article-title":"Exhaled nitric oxide in childhood asthma.","volume":"155","author":"Artlich","year":"1996","journal-title":"Eur J Pediatr"},{"key":"2026032708131680100_B34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1183\/09031936.96.09020196","article-title":"Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients.","volume":"9","author":"Kharitonov","year":"1996","journal-title":"Eur Respir J"},{"key":"2026032708131680100_B35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/ajrccm.153.1.8542158","article-title":"Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.","volume":"153","author":"Kharitonov","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708131680100_B36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/thx.54.5.403","article-title":"Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.","volume":"54","author":"van Rensen","year":"1999","journal-title":"Thorax"},{"key":"2026032708131680100_B37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0091-6749(98)70019-3","article-title":"Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma.","volume":"102","author":"Shapiro","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708131680100_B38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1183\/09031936.01.17508560","article-title":"High or standard initial dose of budesonide to control mild-to-moderate asthma.","volume":"17","author":"Chanez","year":"2001","journal-title":"Eur Respir J"},{"key":"2026032708131680100_B39","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1183\/09031936.97.10061242","article-title":"Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness. Dutch CNSLD Study Group.","volume":"10","author":"Brand","year":"1997","journal-title":"Eur Respir J"},{"key":"2026032708131680100_B40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/thx.54.2.103","article-title":"Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.","volume":"54","author":"Brand","year":"1999","journal-title":"Thorax"},{"key":"2026032708131680100_B41","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1164\/ajrccm.151.6.7767512","article-title":"Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate.","volume":"151","author":"Doull","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708131680100_B42","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJM199712043372304","article-title":"A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.","volume":"337","author":"Simons","year":"1997","journal-title":"N Engl J Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/164\/11\/2073\/67577023\/ajrccm_164_11_2073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/164\/11\/2073\/67577023\/ajrccm_164_11_2073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:13:24Z","timestamp":1774613604000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/164\/11\/2073\/8544843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2001,12,1]]},"published-print":{"date-parts":[[2001,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.164.11.2103075","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,12]]},"published":{"date-parts":[[2001,12,1]]}}}